Laws Atlas / Europe
Peptides in Europe — Law & Status
No research peptide holds a European Medicines Agency (EMA) marketing authorisation. The EMA's guideline on the manufacture of synthetic peptides took effect on 1 June 2026; it governs manufacturing quality, not the status of laboratory research material. Medicines law is enforced nationally, and member states differ on advertising, import and supply details — which is why this atlas keeps a page per country rather than pretending one European answer exists.
The shared baseline: compounds with no marketing authorisation may only be supplied as laboratory research materials, not for human consumption and with no medical claims; prescription-only medicines are supplied only against a prescription from a registered prescriber, dispensed by a registered pharmacy; and every prescriber can be checked on their national register.